Results 141 to 150 of about 86,821 (175)

A Pharmacometrics-Informed Trial Simulation Framework for Optimizing Study Designs for Disease-Modifying Treatments in Rare Neurological Disorders. [PDF]

open access: yesCPT Pharmacometrics Syst Pharmacol
Ryeznik Y   +12 more
europepmc   +1 more source

Overexpression of KMT9α is associated with poor outcome in cholangiocarcinoma patients. [PDF]

open access: yesJ Cancer Res Clin Oncol
Kinzler MN   +13 more
europepmc   +1 more source

KDM4A promotes NEPC progression through regulation of MYC expression. [PDF]

open access: yesCancer Lett
Mak CSL   +37 more
europepmc   +1 more source

Neuropilin-1 expression modulates infection susceptibility to murine cytomegalovirus at the materno-fetal interface. [PDF]

open access: yesJ Virol
Fonseca Brito L   +8 more
europepmc   +1 more source

WienXtra – Workshop "Schule und Gaming"

open access: yesMedienimpulse, 2017
Katharina Kaiser-Müller
doaj  

Sensitization of Non-M3 Acute Myeloid Leukemia Blasts to All-Trans Retinoic Acid by the LSD1 Inhibitor Tranylcypromine: TRANSATRA Phase I Study. [PDF]

open access: yesEur J Haematol
Kruszewski M   +22 more
europepmc   +1 more source

An Investigation of Corticospinal Tract Microstructural Integrity in ARSACS Using a Profilometry MRI Analysis: Results From the PROSPAX Study. [PDF]

open access: yesEur J Neurol
Scaravilli A   +17 more
europepmc   +1 more source

Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growth. [PDF]

open access: yesNat Commun
Jia Y   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy